ATMI Reports Financial Results for the Fourth Quarter of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ATMI Reports Financial Results for the Fourth Quarter of 2013

Revenues Grew 6 Percent Compared With Last Year to $94.8 Million

Income From Continuing Operations Was $0.19 Per Diluted Share

Income Includes Asset Impairment Charge of $0.28 Per Diluted Share and a Gain of $0.03 Per Diluted Share

DANBURY, Conn., Feb. 4, 2014 (GLOBE NEWSWIRE) -- ATMI, Inc. (Nasdaq: ATMI ), a global technology company, today reported financial results for the fourth quarter of 2013.

Revenues from continuing operations were $94.8 million during the fourth quarter of 2013, an increase of 6 percent compared with $89.2 million during the same period last year, lifted by strong demand for products in Microelectronics, especially implant, and eVOLV™ license revenues. Income from continuing operations was $6.4 million, or $0.19 per diluted share, and included a pre-tax asset impairment charge of $11.5 million ($0.28 per diluted share), and a pre-tax gain of $1.2 million ($0.03 per diluted share) on the sale of a marketable security. Excluding these one-time items in the quarter, diluted earnings per share from continuing operations were $0.44. Income from continuing operations during the fourth quarter of 2012 was $11.9 million, or $0.36 per diluted share.

"We concluded 2013 on a strong note in regards to operating performance and strategic objectives," said Chief Executive Officer Doug Neugold. "Microelectronics achieved meaningful revenue growth in a challenging demand environment, and we recognized license revenues for eVOLV, our electronic waste recovery technology. On the strategic front, the divestiture of LifeSciences to Pall Corporation allows us to recognize the value of the business while placing it in the hands of a strategic owner with the desire and ability to grow in single-use technology. Finally, with the pending acquisition by Entegris, Inc., the consolidation we have enabled within the semiconductor supply chain will result in an even stronger supplier of performance materials and related consumable technologies to the world's integrated circuit (IC) producers."

Operating expense increased due primarily to the $11.5 million impairment charge related to certain of our High Productivity Development assets. This action was taken to better align the research and development asset base with the select number of manufacturers producing leading node semiconductors.

ATMI will not conduct a conference call with analysts or investors to discuss these quarterly results due to the pending acquisition by Entegris, Inc. The company expects to file its form 10-K with the SEC on or about March 7, 2014.

About ATMI

ATMI, Inc., a global technology company, provides specialty materials, material processing, and safe, high-purity materials handling and delivery solutions designed to increase process efficiencies for the microelectronics and other industries. For more information, please visit http://www.atmi.com .

ATMI, eVOLV, and the ATMI logo are trademarks or registered trademarks of Advanced Technology Materials, Inc., in the United States, other countries, or both.

Forward Looking Statements

Statements contained herein that relate to ATMI's future performance, including, without limitation, statements with respect to ATMI's anticipated results of operations or level of business for 2014 or any other future period, are forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on current expectations only and are subject to certain risks, uncertainties, and assumptions, including, but not limited to, changes in semiconductor industry growth (including, without limitation, wafer starts) or ATMI's markets; competition, problems, or delays developing, commercializing, and delivering new products; customer-driven pricing pressure; potential loss of key customers; problems or delays in integrating acquired operations and businesses; uncertainty in the credit and financial markets; ability to protect ATMI's proprietary technology; and other factors described in ATMI's Form 10-K for the year ended December 31, 2012 and other subsequent filings with the Securities and Exchange Commission. Such risks and uncertainties may cause actual results to differ materially from those expressed in our forward-looking statements. ATMI undertakes no obligation to update any forward-looking statements.

ATMI, INC.
SUMMARY STATEMENTS OF COMPREHENSIVE INCOME
(in thousands, except per share data)
 
  Three Months Ended December
31,
Twelve Months Ended December
31,
  2013 2012 2013 2012
  (Unaudited) (Unaudited) (Unaudited) (Unaudited)
         
Revenues $94,844 $89,180 $360,959 $365,849
Cost of revenues 47,460 44,577 185,013 179,258
Gross profit 47,384 44,603 175,946 186,591
Operating expenses:        
Research and development 21,591 12,552 55,666 47,286
Selling, general and administrative 18,579 17,103 72,884 73,521
Total operating expenses 40,170 29,655 128,550 120,807
Operating income 7,214 14,948 47,396 65,784
Interest income 249 186 $944 $900
Other income (expense), net 730 285 2,616 ($58)
Income before income taxes 8,193 15,419 50,956 66,626
Provision for income taxes 1,805 3,510 12,197 18,331
Income from continuing operations $6,388 $11,909 $38,759 $48,295
         
Income (loss) from discontinued operations, net of tax (2,544) 711 (8,594) (5,965)
Net income $3,844 $12,620 $30,165 $42,330
         
Earnings per diluted share, continuing operations $0.19 $0.36 $1.18 $1.48
Earnings (loss) per diluted share, discontinued operations ($0.08) $0.02 ($0.26) ($0.18)
         
Weighted average shares outstanding - diluted 32,897 32,679 32,751 32,664
         
Comprehensive income $4,961 $21,490 $23,068 $49,909
   
 
ATMI, INC.
SUMMARY BALANCE SHEETS
(in thousands)
 
     December 31, December 31,
  2013 2012
  (Unaudited)  
Assets    
Cash & marketable securities (1) $128,847 $154,106
Accounts receivable, net 58,009 53,684
Inventories, net 76,485 77,012
Other current assets 39,378 24,313
Assets held for sale 120,618 101,051
Total current assets 423,337 410,166
Property, plant, and equipment, net 120,462 111,720
Marketable securities, non-current (1) 2,225 12,073
Other assets 50,196 65,194
Total assets $596,220 $599,153
     
Liabilities and stockholders' equity    
Accounts payable $27,087 $35,847
Other current liabilities 15,511 31,296
Liabilities held for sale $13,108 $12,377
Total current liabilities 55,706 79,520
Non-current liabilities 11,354 12,357
Stockholders' equity 529,160 507,276
Total liabilities & stockholders' equity $596,220 $599,153
 
(1) Total cash and marketable securities from continuing operations equaled $131.1 million and $166.2 million at December 31, 2013 and December 31, 2012, respectively.

Troy Dewar Vice President, Investor Relations and Corporate Communications 203.207.9349

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Auction Direct USA Offers Budget-Friendly Used Cars

Updated Category News Views 53

Dollars and Sense: Affordable Cars in Raleigh Listen up, folks. These days, unless you're on the hunt for a fancy ride decked out with every bell and whistle, the idea of nabbing a car under ten grand almost sounds like a fairytale. But Auction Direct USA in Raleigh is making this dream a reality. That’s right, a whole fleet of used cars, all priced under $10,000, is...

Continue Reading
Lennox Faces Pressures Amidst Strong Revenue Growth

Updated Category News Views 118

Revenue Surge but Margin Squeeze Out there in the land of HVAC, Lennox International (NYSE: LII) just dropped its third quarter earnings for 2026. Sure, they raked in a solid $1.6 billion—up a hearty 10%. But all that glitters ain't gold, and the company's operating income took a hit down to $312 million, shedding a cool five percent from last year. Challenges Weighing...

Continue Reading
EWTN’s Docuseries 'In Jesus' Name' Explores Exorcisms

Updated Category News Views 50

The True Stories Behind Exorcisms In the complex landscape of media today, EWTN Studio's latest docuseries, In Jesus' Name, steps into the ring with tales that outstrip Hollywood's beloved fright flicks. Forget about the jumpscares and the special effects next to those greased-up eggs you're munching on. This series drills right to the bone of reality—a candid look at...

Continue Reading
Core Lab's Quarterly Grit: Navigating a Turbulent Market

Updated Category News Views 71

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Continue Reading
Small Biz Financing Soars Amid Credit Struggles

Updated Category News Views 64

Record Financing Applications, But Not All is Rosy Diving headlong into this 1West data is like clutching at a double-edged sword. On one side, we've got record-breaking numbers—48,975 financing applications in Q3 alone. That’s a staggering 25% hike over last year. But before you pop the champagne, let's pivot to the other edge: dwindling financial health. With the...

Continue Reading
First Responders Honored in Times Square Hero Ceremony

Updated Category News Views 188

Stepping up to Spotlight Courage In a world that often seems to teeter on chaos, it's those unsung heroes—the first responders—who stand ready to turn panic into repose. October 28th saw Times Square in New York City transform into a beacon of appreciation as the First Responders Children's Foundation (FRCF) applauded nineteen fearless foes of danger. Picture that...

Continue Reading
AEP's $100B Power Plan: Investing in Tomorrow's Energy

Updated Category News Views 75

Electricity Powerhouse Unleashes Ambitious Plan If you thought American Electric Power (NASDAQ:AEP) was just cruising along, think again. This week, they rolled out an eye-popping $100 billion plan to supercharge their infrastructure and meet soaring electricity demands. It’s like they’re building the future of power right in front of our eyes. Third-quarter earnings...

Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030

Updated Category News Views 132

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Continue Reading
Cloopen Group's Private Transition: What Investors Should Know

Updated Category News Views 98

Cloopen Steps Away from Public Market Scene Here's a tale simmering on the corporate backburner: Cloopen Group Holding Limited, that cloud juggernaut over in China, has gone all private on us. The ink is drying on their merger with SummerX Holdings Limited, under the overarching umbrella of SpringX Holdings. So, now this communications outfit has slipped out of the public...

Continue Reading
Long March Reflections: Lesson of Adaptation Endures

Updated Category News Views 50

Ever stood in a place where history feels so heavy you can almost touch it? That's Lazikou, a gorge in southern Gansu, where ninety years ago, young soldiers of China's Red Army faced a seemingly impassable barrier. Yet, they managed to climb, transform a military retreat into legend, and essentially shape the nation's path ahead. It's a feat that still sends ripples...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on the Growing Aeroderivative Gas Turbine Market

Updated Category News Views 259

Aeroderivative Gas Turbine Market Overview The Aeroderivative Gas Turbine market is experiencing remarkable growth, driven by increasing demands for efficient power generation and technological innovations. According to recent analysis, the market is projected to surge to an estimated value of USD 6.79 billion by 2034, marking a compound annual growth rate (CAGR) of...

Continue Reading
Chain.io Unveils Snowflake Integration for Supply Chain Excellence

Updated Category News Views 149

Chain.io Unveils New Snowflake Connectivity Chain.io has introduced an exciting connected application aimed at boosting the capabilities of supply chain teams. This innovative tool provides seamless access to supply chain data, paving the way for deeper insights and improved operational efficiency. Navigating the Complexities of Supply Chain Data Logistics and supply...

Continue Reading
Antalpha's Exceptional Q3 Performance Highlights Growth Potential

Updated Category News Views 151

Antalpha's Impressive Third Quarter Performance Antalpha Platform Holding Company (NASDAQ: ANTA) has recently unveiled promising financial results for the third quarter of this year. This period has proven pivotal as the company marked an extraordinary 62% growth in revenue over the previous year, highlighting the effectiveness of their Prime lending platform. Rapid...

Continue Reading
Class Action Alert for Block, Inc. Shareholders - What to Know

Updated Category News Views 223

Understanding Class Actions and Your Rights If you've faced losses in your investments with Block, Inc. (XYZ), you may feel overwhelmed and uncertain about your next steps. Class action lawsuits can be an effective way for shareholders like you to seek justice and accountability from companies. The Gross Law Firm is reaching out to encourage affected investors to take...

Continue Reading
Acumen Pharmaceuticals Highlights Innovations in Alzheimer's Research

Updated Category News Views 101

Acumen Pharmaceuticals Advances in Alzheimer’s Research Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is at the forefront of developing a promising new treatment aimed at combating Alzheimer's disease. This innovative approach focuses on targeting soluble amyloid beta oligomers (A?Os), a significant physiological...

Continue Reading